Madison Avenue Partners, L.P. 13F annual report
Madison Avenue Partners, L.P. is an investment fund managing more than $792 billion ran by Chris Carroll. There are currently 19 companies in Mr. Carroll’s portfolio. The largest investments include Graham Hldgs Co and Solventum Corp, together worth $294 billion.
$792 billion Assets Under Management (AUM)
As of 7th August 2024, Madison Avenue Partners, L.P.’s top holding is 233,484 shares of Graham Hldgs Co currently worth over $163 billion and making up 20.6% of the portfolio value.
In addition, the fund holds 2,464,934 shares of Solventum Corp worth $130 billion.
The third-largest holding is Globus Med Inc worth $97 billion and the next is Theravance Biopharma Inc worth $72.2 billion, with 8,511,350 shares owned.
Currently, Madison Avenue Partners, L.P.'s portfolio is worth at least $792 billion. The total portfolio value may be much higher due to cash
assets that are not publicly disclosed such as fixed income, real estate, or cash equivalents.
Careers at Madison Avenue Partners, L.P.
The Madison Avenue Partners, L.P. office and employees reside in New York, New York. According to the last 13-F report filed with the SEC, Chris Carroll serves as the CCO at Madison Avenue Partners, L.P..
Recent trades
In the most recent 13F filing, Madison Avenue Partners, L.P. revealed that it had opened a new position in
Solventum Corp and bought 2,464,934 shares worth $130 billion.
The investment fund also strengthened its position in Graham Hldgs Co by buying
24,083 additional shares.
This makes their stake in Graham Hldgs Co total 233,484 shares worth $163 billion.
On the other hand, there are companies that Madison Avenue Partners, L.P. is getting rid of from its portfolio.
Madison Avenue Partners, L.P. closed its position in G-III Apparel on 14th August 2024.
It sold the previously owned 3,188,997 shares for $79.5 billion.
Chris Carroll also disclosed a decreased stake in Sharkninja Inc by 0.9%.
This leaves the value of the investment at $54.2 billion and 721,578 shares.
One of the average hedge funds
The two most similar investment funds to Madison Avenue Partners, L.P. are Capwealth Advisors and Johnson. They manage $791 billion and $792 billion respectively.
Chris Carroll investment strategy
Madison Avenue Partners, L.P.’s portfolio is diversified across 5 sectors.
Currently, their heaviest sector is Health Care — making up 15.8% of
the total portfolio value.
The fund focuses on investments in the United States as
31.6% of the portfolio companies
are based in the United States.
The majority of the companies in the fund’s portfolio are large-cap stocks.
Stocks with a size of more than $10 billion in market cap make up
5% of the total holdings value.
On the other hand, small-cap stocks make up only approximately 0.1% of the portfolio.
The average market cap of the portfolio companies is close to $3.21 billion.
The complete list of Madison Avenue Partners, L.P. trades based on 13F SEC filings
These positions were updated on August 14th based on the fund’s latest 13F filing. Quickly find out what the most recently closed or increased positions are.
| Security | Shares Owned | Value | Allocation |
|---|---|---|---|
| Graham Hldgs Co |
11.50%
233,484
|
$163,333,732,000 | 20.63% |
| Solventum Corp |
Opened
2,464,934
|
$130,345,710,000 | 16.47% |
| Globus Med Inc |
Opened
1,416,168
|
$96,993,346,000 | 12.25% |
| G-III Apparel Group Ltd. |
Closed
3,188,997
|
$79,469,805,000 | |
| Theravance Biopharma Inc |
21.38%
8,511,350
|
$72,176,248,000 | 9.12% |
| Wiley John Sons Inc |
Opened
1,630,517
|
$66,362,042,000 | 8.38% |
| Sharkninja Inc |
88.19%
721,578
|
$54,226,587,000 | 6.85% |
| QuidelOrtho Corporation |
Opened
1,497,148
|
$49,735,257,000 | 6.28% |
| Stagwell Inc |
No change
7,147,662
|
$48,747,055,000 | 6.16% |
| Integra Lifesciences Hlds C |
Closed
964,667
|
$36,840,633,000 | |
| Nelnet Inc |
Opened
290,213
|
$29,270,883,000 | 3.70% |
| Ducommun Inc. |
Opened
382,495
|
$22,207,660,000 | 2.81% |
| PFSWEB Inc |
Closed
2,633,189
|
$19,590,926,000 | |
| Orion Group Holdings Inc |
Closed
3,501,281
|
$18,241,674,000 | |
| Atmus Filtration Technologies Inc |
Opened
415,366
|
$11,954,233,000 | 1.51% |
| News Corp |
Opened
480,574
|
$13,292,503,000 | 1.68% |
| 2seventy Bio Inc |
71.55%
2,563,222
|
$9,868,405,000 | 1.25% |
| Merrimack Pharmaceuticals Inc |
Closed
553,085
|
$6,819,538,000 | |
| Gossamer Bio, Inc. |
Closed
6,130,268
|
$5,105,287,000 | |
| Franklin Str Pptys Corp |
No change
3,291,443
|
$5,035,908,000 | 0.64% |
| Zimvie Inc |
Opened
270,927
|
$4,944,418,000 | 0.62% |
| Selecta Biosciences Inc |
Closed
4,008,019
|
$4,248,500,000 | |
| Indivior Plc |
471.63%
223,432
|
$3,601,724,000 | 0.46% |
| Central Eastern Europe Fd |
59.71%
337,046
|
$3,592,910,000 | 0.45% |
| Ovid Therapeutics Inc |
11.88%
4,082,100
|
$3,139,951,000 | 0.40% |
| MBIA Inc. |
Closed
420,826
|
$3,034,155,000 | |
| HomeStreet Inc |
Opened
240,903
|
$2,746,294,000 | 0.35% |
| Vestis Corporation |
Closed
110,000
|
$2,123,000,000 | |
| Lensar Inc |
Closed
240,341
|
$742,654,000 | |
| Safeguard Scientifics, Inc. |
Closed
359,085
|
$359,085,000 | |
| No transactions found | |||
| Showing first 500 out of 30 holdings | |||
Hedge funds similar to Madison Avenue Partners, L.P.
- Central Pacific Bank - Trust Division
- Willow Creek Wealth Management
- Certified Advisory Corp
- Unison Advisors
- Van Cleef Asset Management,inc
- Kovack Advisors
- Johnson
- Capwealth Advisors
- Cortland Associates Inc/mo
- Apriem Advisors
- Spectrum Wealth Counsel
- Ninepoint Partners L.P.
- Bfsg
- First American Trust, Fsb